Voltar
Artigo Revisado por pares
BIBTEX RIS

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

2010; Elsevier BV; Volume: 63; Issue: 3 Linguagem: Inglês

10.1016/j.jaad.2009.09.014

ISSN

1097-6787

Autores

Richard Langley, Steven R. Feldman, Chenglong Han, Brad Schenkel, Philippe Szapary, Ming-Chun Hsu, Jean-Paul Ortonne, Kenneth B. Gordon, Alexa B. Kimball,

Tópico(s)

Pregnancy and Medication Impact

Referência(s)